EUROmediCAT signal detection: a systematic method for identifying potential teratogenic medication
Michiel Luteijn(Queen Mary University of London), Helen Dolk(University of Ulster), Maria Loane(University of Ulster), Joanne Given(University of Ulster), Marian K. Bakker(University Medical Center Groningen), Joan K. Morris(St George's, University of London), David Tucker(UNSW Sydney), Anna Latos‐Bieleńska(Poznan University of Medical Sciences), Lolkje de Jong‐van den Berg(University of Groningen), Ester Garne(University of Southern Denmark), Kari Klungsøyr(Norwegian Institute of Public Health), Vera Nelen(Provincial Institute for Hygiene), Anna Pierini(Istituto di Fisiologia Clinica), Mary O’Mahony(Health Service Executive), Ingeborg Barišić(University of Zagreb), Miriam Gatt(Ministry for Health), Nathalie Lelong(Inserm), Amanda J. Neville(University of Ferrara), Hermien E. K. de Walle(University of Groningen), Marie‐Claude Addor(University Hospital of Lausanne), Awi Wiesel(Johannes Gutenberg University Mainz)
Cited by 11
Related Papers
Randomized Trial of Preventive Angioplasty in Myocardial Infarction
|New England Journal of Medicine|2013|1k
Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials
|The American Journal of Medicine|2009|941
UK health performance: findings of the Global Burden of Disease Study 2010
|The Lancet|2013|557
Cardiovascular morbidity and mortality after orthotopic liver transplantation
|Transplantation|2002|326
A Role for Protein Kinase Bβ/Akt2 in Insulin-Stimulated GLUT4 Translocation in Adipocytes
|Molecular and Cellular Biology|1999|318